Vasoactive intestinal peptide (VIP) induces IL-6 and IL-8, but not G- CSF and GM-CSF release from a human bronchial epithelial cell line

Neuropeptides

Volumn 31, Issue 2, 1997, Pages 119-124

  Mullol, J ^a,b   Baraniuk, J N ^c   Pitale, M ^a   Benfield, T ^a   Logun, C ^a   Picado, C ^b   Shelhamer, J H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NEUROPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; BRONCHUS MUCOSA; CELL SECRETION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

BRONCHUS;

EID: 0030898069     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90079-2     Document Type: Article

References (32)

1. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144: 1187-1198.
2. Harmar T, Lutz E. Multiple receptors for PACAP and VIP. TIPS 1994; 15: 97-98.
3. Laitinen A, Partanen M, Hervonen A, Peto-Huikko M, Laitinen LA. VIP-like immunoreactive nerves in human respiratory tract. Light and electron microscopic study. Histochemistry 1985; 82: 311-319.
4. Cutz E, Chan W, Track NS, Goth A, Said SI. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 1978; 275: 661-662.
5. Aliakabari J, Sreedharan SP, Truck CW, Goetzl EJ. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Commun 1987; 148: 1440-1445.
6. Baraniuk JN, LundgrenJD, Okayama M et al. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest 1990; 86: 825-831.
7. Mullol J, Rieves RD, Baraniuk JN et al. The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitro. Neuropeptides 1992; 21: 231-238.
8. O'Dorisio MS, Shannon BT, Fleshman DJ, Campolito LB. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage. J Immunol 1989; 142: 3533-3536.
9. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89: 1001-1009.
10. Mullol J, Xaubet A, Gaya A et al. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 1995; 25: 607-615.
11. Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1 and interleukin-6. AmJ Respir Cell Mol Biol 1993; 8: 20-27.
12. Cohen AM, Zsebo KM, Inoue H et al. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1987; 84: 2484-2488.
13. Wang JM, Chen ZG, Colella S et al. Chemotactic activity of recombinant human granulocyte colony stimulating factor. Blood 1988; 72: 1456-1460.
14. Cox G, Gauldie J, Jordana M. Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promoted the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992; 7: 507-513.
15. Nathan CF. Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 1989; 73: 301-306.
16. Xaubet A, Mullol J, López E et al. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy 1994; 24: 307-317.
17. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765-788.
18. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
19. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
20. Leonard EJ, Yoshimura T. Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Respir Cell Mol Biol 1990; 2: 479-486.
21. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB. Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993; 23: 1027-1036.
22. Levine SJ, Larivée P, Logun C, Angus CW, Shelhamer JH. Corticosteroids differentially regulate secretion of IL-6, IL-8 and G-CSF by a human bronchial epithelial cell line. Am J Physiol 1993; 265: L360-L368.
23. Eskay RL, Eiden LE. Interleukin-1 alpha and tumor necrosis factor-alpha differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells. Endocrinology 1992; 130: 2252-2258.
24. Ollerenshaw S, Jarvis D, Woolckock A, Sullivan C, Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 1989; 320: 1244-1248.
25. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. AmJ Respir Crit Care Med 1995; 151: 548-553.
26. Reddel RR, Ke Y, Gerwin BI et al. Transformation of human bronchial epithelial cells by infecting with SV40 or adenovirus-12 SV40 hybrid virus and transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988; 48: 1904-1909
27. Ke Y, Reddel RR, Gerwin BI, Miyashita M, McMenamin M, Lechner JF. Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. Differentiation 1988; 38: 60-66.
28. Scudiero DA, Shoemaker RH, Paull KD et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other cell lines. Cancer Res 1988; 48: 4827-4833.
29. Said SI. VIP as a modulator of lung inflammation and airway constriction. Am Rev Respir Dis 1991; 143: S22-S24.
30. Rovati GE, Nicosia S. Lower efficacy: interaction with an inhibitory receptor or partial agonism? TIPS 1994; 15: 140-144.
31. Carstairs JR, Barnes PJ. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung. J Pharmacol Exp Ther 1986; 239: 249-255.
32. Haegerstrand A, Jonzon B, Dalsgaard CJ, Nilsson J. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc Natl Acad Sci USA 1989; 86: 5993-5996.